We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
-0.22%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
AUM
$11.2B
AUM Growth
+$94.1M
Cap. Flow
-$92.7M
Cap. Flow %
-0.83%
Top 10 Hldgs %
77.28%
Holding
1,482
New
520
Increased
341
Reduced
150
Closed
461

Sector Composition

Rank Sector Weight
1 Financials 2.04%
2 Industrials 2.03%
3 Technology 2.03%
4 Healthcare 1.6%
5 Consumer Discretionary 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LQDA icon
926
Liquidia Corp
LQDA
$8.02B
$154K ﹤0.01%
+12,855
New +$171K
KRNT icon
927
Kornit Digital
KRNT
$791M
$154K ﹤0.01%
+10,495
New +$162K
AGS
928
DELISTED
PlayAGS
AGS
$153K ﹤0.01%
+13,262
New +$137K
VYGR icon
929
Voyager Therapeutics
VYGR
$201M
$148K ﹤0.01%
+18,707
New +$157K
DBRG icon
930
DigitalBridge
DBRG
$2.95B
$148K ﹤0.01%
10,771
-49,459
-82% -$745K
MTW icon
931
Manitowoc
MTW
$675M
$145K ﹤0.01%
+12,616
New +$156K
CDLX icon
932
Cardlytics
CDLX
$21.5M
$144K ﹤0.01%
+1,752
New +$189K
CRNC icon
933
Cerence
CRNC
$413M
$144K ﹤0.01%
+50,711
New +$361K
DENN
934
DELISTED
Denny's
DENN
$143K ﹤0.01%
+20,184
New +$156K
BMEA icon
935
Biomea Fusion
BMEA
$91.3M
$141K ﹤0.01%
+31,379
New +$319K
PLTK icon
936
Playtika
PLTK
$1.12B
$139K ﹤0.01%
17,698
-9,703
-35% -$77K
ALLO icon
937
Allogene Therapeutics
ALLO
$694M
$139K ﹤0.01%
59,705
+27,519
+85% +$81.2K
MERC icon
938
Mercer International
MERC
$39.8M
$139K ﹤0.01%
16,226
+4,193
+35% +$40.4K
ACH
939
Accendra Health
ACH
$214M
$138K ﹤0.01%
+10,207
New +$209K
SSP icon
940
E.W. Scripps
SSP
$304M
$137K ﹤0.01%
43,647
+24,164
+124% +$76.5K
SBH icon
941
Sally Beauty Holdings
SBH
$1.58B
$133K ﹤0.01%
+12,350
New +$136K
FOLD
942
DELISTED
Amicus Therapeutics
FOLD
$131K ﹤0.01%
+13,175
New +$135K
SPCE icon
943
Virgin Galactic
SPCE
$398M
$129K ﹤0.01%
+15,249
New +$276K
AIV
944
Aimco
AIV
$383M
$127K ﹤0.01%
+15,364
New +$124K
CRBU icon
945
Caribou Biosciences
CRBU
$164M
$126K ﹤0.01%
77,121
+66,867
+652% +$214K
VTEX icon
946
VTEX
VTEX
$713M
$124K ﹤0.01%
+17,141
New +$124K
UIS icon
947
Unisys
UIS
$217M
$124K ﹤0.01%
+30,089
New +$147K
KRNY icon
948
Kearny Financial
KRNY
$599M
$122K ﹤0.01%
19,823
+3,229
+19% +$18.5K
NKLA
949
DELISTED
Nikola Corporation Common Stock
NKLA
$121K ﹤0.01%
+14,762
New +$263K
SEI
950
Solaris Energy Infrastructure
SEI
$3.82B
$120K ﹤0.01%
14,025
-3,615
-20% -$31.6K

Similar funds

Brevan Howard Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Brevan Howard Capital Management held 1,482 positions worth $11.2B, up 0.85% from $11.1B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Brevan Howard Capital Management's Q2 2024 filing shows 520 new, 341 increased, 150 reduced and 461 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 750,000 shares worth $57.9M. The largest sale was Workday, an estimated $31.5M.

By sector, the portfolio is most concentrated in Financials at 2% of assets, up from 1.5% a quarter earlier, followed by Industrials and Technology.

  • Brevan Howard Capital Management's largest Q2 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 750,000 shares worth $57.9M.
  • Brevan Howard Capital Management added most to Apple in Q2 2024, an estimated $23.6M increase.
  • Brevan Howard Capital Management's biggest Q2 2024 reduction was Elastic, cutting an estimated $11.1M.
  • Brevan Howard Capital Management fully exited Workday in Q2 2024, selling an estimated $31.5M.
  • Brevan Howard Capital Management's ten largest holdings make up 77% of its $11.2B portfolio in Q2 2024.
  • Brevan Howard Capital Management opened 520 new positions and closed 461 in Q2 2024.
  • Brevan Howard Capital Management's portfolio value rose 0.85% quarter-over-quarter to $11.2B.

Based on Brevan Howard Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.